SDC1 and Miyoshi myopathy: Studies reported that TMP, PMP, and CD138+MP were elevated in patients with MM compared to healthy controls with significant prognostic potential of CD138+MPs in predicting the response to treatment and risk of relapse31, our results agreed with the previous study.